Deepika Jalota

Insider Reports History

Location
Cranbury, NJ
Signature
/s/ Robert Ticktin, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Deepika Jalota:

Company Role Class Num Shares Value Price $ Report Date Ownership
PMV Pharmaceuticals, Inc. Chief Development Officer Common Stock 89,959 $95,761 $1.06 01 Jul 2025 Direct
PMV Pharmaceuticals, Inc. Chief Development Officer Employee Stock Option (right to buy) 300,000 03 Mar 2025 Direct

Insider Reports Filed by Deepika Jalota

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PMVP PMV Pharmaceuticals, Inc. 01 Jul 2025 1 -$35,198 4 Chief Development Officer 03 Jul 2025, 19:50
PMVP PMV Pharmaceuticals, Inc. 03 Mar 2025 1 $0 4 Chief Development Officer 05 Mar 2025, 18:32
PMVP PMV Pharmaceuticals, Inc. 11 Sep 2024 1 -$10,853 4 Chief Development Officer 12 Sep 2024, 18:00
PMVP PMV Pharmaceuticals, Inc. 13 Aug 2024 5 $0 4 Chief Development Officer 03 Oct 2024, 16:50
PMVP PMV Pharmaceuticals, Inc. 18 Jan 2024 2 $0 4 Chief Development Officer 22 Jan 2024, 16:06
PMVP PMV Pharmaceuticals, Inc. 15 Sep 2023 1 -$27,168 4 Chief Development Officer 18 Sep 2023, 17:26
PMVP PMV Pharmaceuticals, Inc. 12 May 2023 1 $0 4 Chief Development Officer 15 May 2023, 18:18
PMVP PMV Pharmaceuticals, Inc. 09 Sep 2022 1 $0 4 SVP, Regulatory Affairs and QA 13 Sep 2022, 16:26
PMVP PMV Pharmaceuticals, Inc. 10 Feb 2022 1 $0 4 SVP, Regulatory Affairs and QA 28 Feb 2022, 15:28
PMVP PMV Pharmaceuticals, Inc. 17 Aug 2021 3 -$87,591 4 SVP, Regulatory Affairs and QA 18 Aug 2021, 17:02
PMVP PMV Pharmaceuticals, Inc. 12 May 2021 1 $0 4 SVP, Regulatory Affairs and QA 08 Jun 2021, 19:24